Nanosphere Respiratory Panel Categorized as Moderate Complexity | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere today said that the US Food and Drug Administration has notified the firm that its Verigene SP respiratory virus panel has been categorized as "moderate complexity" under the Clinical Laboratory Improvement Amendments of 1988.

The test runs on the firm's Verigene SP molecular diagnostics system, the newer version of its flagship Verigene platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.